The European Union should allow drug prices to rise to U.S. levels in order to attract investment, the bosses of two European pharmaceutical giants said in a letter published in the Financial Times on ...

Robert is currently chief digital officer at the cruise line firm Viking Cruises and will join Sanofi on 15th June. His brief is to drive Sanofi’s digital, data and technology strategy ...

With many patients having “resigned themselves to their condition,” according to Sanofi CEO Paul Hudson, the company is busy educating pulmonologists and patients about the benefits of the ...

Paul Hudson, CEO at Sanofi, said: “Sanofi’s purpose in chasing the miracles of science reaches far beyond our labs […] This capital commitment signals Sanofi’s accelerated ambitions in the ...

Pharma executives emphasise that without urgent action, Europe may face a decline and an acceleration in the departure of ...

Brandicourt, known for his tenure as CEO of Sanofi S.A., brings extensive experience in the biopharmaceutical industry, particularly in the vaccine market. According to InvestingPro data ...

The letter came days after von der Leyen met with pharma CEOs. In the meeting, Sanofi CEO Paul Hudson criticized European governments for underpaying for innovation, according to an industry ...

Sanofi CEO Paul Hudson added at the time that “if safety is right, the combination opportunity is significant.” Sanofi expects to publish phase 2 data on balinatunfib in rheumatoid arthritis ...

Novartis CEO Vas Narasimhan and Sanofi leader Paul Hudson wrote in Britain's Financial Times that European price controls and austerity measures reduce the attractiveness of its markets.

Brandicourt, known for his tenure as CEO of Sanofi S.A., brings extensive experience in the biopharmaceutical industry, particularly in the vaccine market. According to InvestingPro data, Vaxcyte ...